Diaceutics PLC
PDMR Shareholding/Share Incentive Plan
and Total Voting Rights
Belfast and London, 30 April 2024
- Diaceutics
PLC (AIM: DXRX), a leading technology and
solutions provider to the pharma and biotech industry, has
been notified that on 26 April 2024, Global Shares
Trustees (UK) Limited (the "UK Trust") and Zedra Trust
Company (Guernsey) Limited, the trustees of the Global Diaceutics
plc 2020 Employee Benefit Trust, have
purchased ordinary shares of £0.002 in the capital of the Company
("Shares") on behalf of Susanne Munksted, Jordan Clark, Julie
Browne, Nick Roberts and Jillian Beggs (PDMRs), in respect of their
purchase of Shares pursuant to the Company's UK and Global Share
Incentive Plan ("the SIP Schemes") for
employees. These purchases will be made each month
until further notice.
In accordance with the SIP Schemes, the Company
has matched these purchases with a matched share award over an
equivalent number of Shares purchased by the employee, in the
proportion of 1:1.
As announced on 2 October 2023, application was
made to AIM for a block listing of 1,500,000 Shares to facilitate
the admission of the Shares to trading following the exercise of
options inter alia under the SIP Schemes. Therefore, the matched
share awards for the UK PDMRs, along with those for all other
participants in the UK SIP Scheme, have been settled by the Company
issuing 8,765 Shares on 29 April 2024 to the UK Trust. The Trust
will hold these Shares on behalf of participants until they vest in
accordance with the UK Scheme rules.
Following the issue of Shares on 29 April,
Diaceutics has 84,705,551 Shares in issue. This figure may be used
by shareholders in the Company as a denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change in their interest in, the
share capital of the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Enquiries:
|
Diaceutics
PLC
|
Tel: +44 (0)28 9040
6500
|
|
Nick Roberts, Chief Financial
Officer
|
investorrelations@diaceutics.com
|
|
|
|
|
Stifel
Nicolaus Europe Limited (Nomad & Broker)
|
Tel: +44 (0)20 7710
7600
|
|
Ben Maddison
|
|
|
Nick Harland
|
|
|
Kate Hanshaw
|
|
|
|
|
|
Alma Strategic
Communications
|
Tel: +44(0)20 3405
0205
|
|
Caroline Forde
|
diaceutics@almastrategic.com
|
|
Kinvara Verdon
|
|
About Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease
outcome.
We provide the world's leading
pharma and biotech companies with an end-to-end commercialisation
solution for precision medicines through data analytics, scientific
and advisory services enabled by our platform DXRX - The
Diagnostics Network ®.
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Susanne Munksted
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Precision Medicine Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Global Share Incentive Plan ("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
1.0299 p
|
145
|
|
|
|
Conditional share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
145
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Conditional share
award: 26 April 2024
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Conditional share award:
Off-Market
|
|
|
|
|
|
|
|
| |
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Jordan Clark
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Data Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Diaceutics plc UK Share Incentive Plan
("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
1.0299 p
|
145
|
|
|
|
Matched share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
145
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Matched Share
award: 26 April 2024
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Matched Share Award:
Off-Market
|
|
|
|
|
|
|
|
| |
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Julie Browne
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Operations Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Diaceutics plc UK Share Incentive Plan
("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
1.0299 p
|
145
|
|
|
|
Matched share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
145
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Matched Share
award: 26 April 2024
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Matched Share Award:
Off-Market
|
|
|
|
|
|
|
|
| |
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Nick Roberts
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Finance Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Diaceutics plc UK Share Incentive Plan
("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
1.0299 p
|
145
|
|
|
|
Matched share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
145
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Matched Share
award: 26 April 2024
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Matched Share Award:
Off-Market
|
|
|
|
|
|
|
|
| |
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Jillian Beggs
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Commercial Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Diaceutics plc UK Share Incentive Plan
("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
1.0299 p
|
145
|
|
|
|
Matched share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
145
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Matched Share
award: 26 April 2024
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Matched Share Award:
Off-Market
|
|
|
|
|
|
|
|
| |